{"ticker": {"uuid": "25fde5c9-969b-4b96-a675-d0381f58a1cb", "symbol": "COAG", "name": "Hemab Therapeutics Holdings, Inc. Common Stock", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Hemab Therapeutics (NASDAQ:COAG) Trading Down 3.8% - Should You Sell?", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxQRG5GcGVsakpUb3FoS3FPODlxMkdpQ0daYWZuNlMxSDlvVG1Rc3I5ODVONTdjVXd5NHEtX2VqcnVPTFpMT2pUX2VLbjNYYy15TWFuUGVBeHFwSElJTW04Uy1YaXlCNFpqN0dKOEx3OWJFRzAyQmQ5SFp1eEtCMTk3S25yUkV4YUFNbnhWeHQwRWNMMzNnbWhEaTZuVzJlTWlLOHROZlVGTnlSTWRscW1uWGw4dnVmUQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-15T16:26:57+00:00", "published_display": "15 Jul 2026 16:26", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Therapeutics: A Cash-Rich Coagulation Franchise With Multiple Clinical Catalysts", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxPdFliWmFUNnhhcWxQZFpIMlN1OWI0WlNsLUdWSWxxMVNtODVWSGMwQlpHX1QxSW51dDVSZzBybW4ydllrdGNGYks5S1ZINmJNdi1sTEdPY1lVQkRBd0ZSX05neFVGNF96cDBHeGpBenNSUGtTR29EV2xJSlZCR2VRekJjM243OU5GR2R6UVBwSEt4clIwVExyZmhkRUZGVGZFeWFCaW1xTlVrOUxoX0FKUjVwR0VGYU1rZnl0c2x3aXMxWGFJY1V1c3AtejZxYnF3?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-15T07:52:28+00:00", "published_display": "15 Jul 2026 07:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxQSW9mM3I5d1lnaHgzVDlPNFgzSVg3MFNNVmk0N0hLcGh3dko0MF9kWUVzS1phTmdDU1NjUGFZamZZWTBmdnFfanllME9NWmhxd0JiMjJzM3JCQU9SVnY0cEx3T3JnT1pDUlh3Vy0xR1lDem9hZ2ZqdUFXd2UzU1JRbkczUEdHZ1hSRGdTN1JfSHgtLUxQVTBJRjNGbS15Z05pZVd0a25wZl9OX0VjNnp4WHVVOUxxeUVwbTJ1TmdMTzZvcEZVbTkzSDdEUFhvZTdtZC1fb3R2SFZ4ZzQ?oc=5", "source_name": "StockStory", "published_at": "2026-07-15T07:00:00+00:00", "published_display": "15 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "symbol__ Stock Quote Price and Forecast", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE5KdjVOVWFBTG9HVTZVZXNKUGFEUmQ1WjdLbDRRaXlyTW5hcWpyVFdPMDhYMzg2OVJxSXhsem0zN1BhRG5xRFhtWEZIT2RualVX?oc=5", "source_name": "CNN", "published_at": "2026-07-15T01:05:31+00:00", "published_display": "15 Jul 2026 01:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Therapeutics reports positive Phase 2 sutacimig data", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNT3NjVXhld2ZVZDNEcXk0WEVFTGExRnVvV1RSRjNCRTFOS2h4YkJxMHdiYW81UTdmUXRtbkppYjJqUkVJTXprb0g3eTVvOW92aUZQZ3VnUXdrdDNIZk5kVzV2WjJaNlJpS20yVWpKcVNrc2ptaG9rZDhzbXNPQXIxRzBKVVhyVEhKMDRiXw?oc=5", "source_name": "grafa.com", "published_at": "2026-07-14T16:28:00+00:00", "published_display": "14 Jul 2026 16:28", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Therapeutics (COAG) FDA Approvals, PDUFA Dates & Drug Alerts 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiaEFVX3lxTE92dDhuUkJRWWJjX09DQVJhS2RjUXR6cERQOVh6SmV2UElVby04al9xXzNvR1NILTJnejRlQjNsTDF0MGw2NTQ2U2FRclNFYS1UY3FfbjFyZzRvb0RQYWZ1UTkxS2NtMndH?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-14T16:19:28+00:00", "published_display": "14 Jul 2026 16:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Advances Bleeding Disorder Pipeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQYUMtVGc3VGRpUTVzVjlzdXh2SFBmS3FwOExqalFLbGlFejJBM2ZEZ3NLNDMxM1phV2ZPSFhiVzM2M3BwSC1hWlVUSHkwTWJoWkFIZVRTRVlKQjQ0dkNPbWxCWTdldU5SdTU2dzlKbXVYaGR6c0p1TkNTUDh6TlZOYmt4NVhwUElfUzVsYTdoakNyby1ZeHFnMg?oc=5", "source_name": "Sahm", "published_at": "2026-07-14T13:24:44+00:00", "published_display": "14 Jul 2026 13:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Therapeutics Presents Clinical and Preclinical Data from Sutacimig in Glanzmann Thrombasthenia and Factor VII Deficiency at the ISTH 2026 Congress", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/hemab-therapeutics-presents-clinical-preclinical-114500576.html", "source_name": "GlobeNewswire", "published_at": "2026-07-14T11:45:00+00:00", "published_display": "14 Jul 2026 11:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab GT study finds 72% of patients 40+ still bleed weekly", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPTmE1NUNZWUl2ZGpSVVN6YzNWcWZDV2RXeU9UeWRYeE5vdk4wUHFpdmlITVFqNlZmYko0WXdjVTdpQVFPX3NNV1duUGxDc1RLNGZnRDZadDdjVzE1TXF3cGxLSXNkX0ZKSkVHcEN3SmNEbmNaVmNLam9BMV9vNEI0QkJpaG1QV2lLTEVkTkcyOTB6YjM2VjJidGtJbWg4YVhYUGt6X0J2Q3JOV3NvRXlQWWFRdGdyZTdP?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-14T11:45:00+00:00", "published_display": "14 Jul 2026 11:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jefferies Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Raises Target Price to $47", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOOHZoTlo2SkEwMTRPV0xZRVR0cktTSWh4QzIzalZqN1B4LWk2eFlfaFVNWG9IR2lkWWZUR0M2UHJNM05kc3RXcl9lZF9oM3BOdmF6TVROaEhKdXN3NkVrM2lNMG5iTG5SOTliRy1fa0RreHBhRmlJOGdXNkNoWTNaSmRxOVpDSm1vT0FlX3NXRnd3M1hfUEZha2N3al9zd1lvcmU0M3B2MDNNdmlXUG43ak5ic0JpeFpLLWc?oc=5", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-14T11:34:47+00:00", "published_display": "14 Jul 2026 11:34", "sentiment": "positive", "sentiment_pct": 82, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "H.C. Wainwright Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Raises Target Price to $52", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQM0h4YUE1YVE4RDVvcS1ld05yOUoxUzVkWXg2ZmRxd212eFFLTDRHTmx6cnhtWlcyM2NkQk9JTWZwRXhsM29qVEdUSUN6bkhGczE2dGVFcHhTb3lwOUtidU4xUlFhNllhdk53ak1LM05VQnlJQjFWUnRybG9UWDktYWJYMXZOWk1sRFIyUU1wMG5WT29pSGx0OXg4bXJyeTRNRUNfc21aOGNvUmd1OXNMaDJ5WUZJM00?oc=5", "source_name": "Moomoo", "published_at": "2026-07-14T03:53:03+00:00", "published_display": "14 Jul 2026 03:53", "sentiment": "positive", "sentiment_pct": 82, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Therapeutics' HMB-002 Well Suited for Type 1 Von Willebrand Disease, Wedbush Says", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/hemab-therapeutics-apos-hmb-002-144209017.html", "source_name": "MT Newswires", "published_at": "2026-07-13T14:42:09+00:00", "published_display": "13 Jul 2026 14:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Therapeutics (NASDAQ:COAG) Earns Outperform Rating from Wedbush", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOZVptNWRMYWdxV1RodmQ4UkV4aVU4LXNyTkhHZGJPUkRSRXN3QS1FU3EzSXB5aUw4SkFxLWxEN1p6cVlXS3lfUUJHaUc1b0FJMDJTNEpReW5pVzlCSHI3OFFmYlFGSlNlUWd5bnhNU1lMQ25CQl9tVDFIV0tCWHpBdXJSd2dTUXgtN2hTa0tRS09iWXpWRXZEcFZpd3ZqYjZZU1F6OG5TX0dCbGRWcW1CYUFiUVBMMXJaYkVDOQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-13T13:43:55+00:00", "published_display": "13 Jul 2026 13:43", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Therapeutics (NASDAQ:COAG) Price Target Raised to $52.00 at HC Wainwright", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxONTRpZ1JXMHNESHcwNG9FMENhYmJqNW1PVEhCcUlIN0k4ZkEzUnBtZC1OQkQwTnpLSUVvWWRBSGJRN00zSzJZYW9sMWMzUFUyNTJ2YUQzcDFtMC1kZWR0Q2ZHcG1xX1ZyU1E2ck5oVk83bnEzcE9qTEd2YnBKdTBpbVd4R1luNVUwN2VJRHJXZTVpYWMxQnZPZHR0Y2Y5TDBZMFVvQ3JnUFRubmd3enJPSTZrRXNIUVc3eDJvcWQxRHVhY1hCNk44?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-13T12:39:22+00:00", "published_display": "13 Jul 2026 12:39", "sentiment": "positive", "sentiment_pct": 64, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Wedbush Raises Price Target on Hemab Therapeutics to $55 From $42, Keeps Outperform Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/wedbush-raises-price-target-hemab-105444800.html", "source_name": "MT Newswires", "published_at": "2026-07-13T10:54:44+00:00", "published_display": "13 Jul 2026 10:54", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPQ3B5MlVsTlBhcXdmUVllazV2SWFHTmRudHVNdFY3RUYtR1FTXzNIV1VYODF0bTMyVThkOE1LZC11TGN2dUxBZzRPTDQxUDVDdF9PWW5VUk1rZVJkdXRjbTQ2MU1wa3BtejZ5NUhWY1dQLUZLS3duak1fMzIxcnNwUmc4X3N5Q1JXMFNQY1J0ZVd5aHF4NHVUQkpnNlNUU1VWcVljNjhGbkFicUNyOXktR0lZWkVxT09oU0VQZnZObG5RMkJDWHh4czRrUktNZFNrZVhKWnF1YTZ2ZmVzTG14WG1n?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:24:17+00:00", "published_display": "13 Jul 2026 09:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/hemab-therapeutics-presents-clinical-data-102800569.html", "source_name": "GlobeNewswire", "published_at": "2026-07-12T10:28:00+00:00", "published_display": "12 Jul 2026 10:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the ISTH 2026 Congress", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/hemab-therapeutics-present-clinical-preclinical-130000267.html", "source_name": "GlobeNewswire", "published_at": "2026-06-26T13:00:00+00:00", "published_display": "26 Jun 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Therapeutics stock jumps on pipeline data presentation", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNZm50VGp3NGlXQzVQTUVqMXV4N19hTWJ3ZVlZdldUN0h3T29USk9CVUlEVzNJd1IzUDZtcG14TC1RYTJieVNIbmthaktsQlB3QnpHWXdUcnBQbHpsazBuZ3JqLWpubG80UWZEMlQ3Q1Z3VzhRWmI1OU9qYWc4QndnRS00WW9hRlQ0SldTNzQzZnVscE5IN1dFa1hoMklJV2xQTWNzcC1SN2RRMUJHa0ZIbU85VTJrUXExZGtyb04xVQ?oc=5", "source_name": "Investing.com", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab brings nine bleeding-disorder studies to ISTH 2026 in Paris", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNTms5MGJFanUxSXMxRWFCZ2lpNklnY3JJVmNUMm1lSXFnTGhxQWtqWU9xRkRudWtHUEdtZkppZDhMQ2kyaHNuZi1GMEFndFNKMnhfSmJpTTBwRWgxWjFDSlIydm92UXNIRThBTGxOblVJNll6dEFDRWYxWllYa05xd2x3THpnMVRqVndkdllXWUg5Mk1BbTFrbkhmMDVrWHE2NDhXRE5wY3l1SHFJQmVmbV9GWjNhTG9FRGw4?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQM0ExNm9zZVBVMzB2cTFsYkhQeDJyeUV5Y1lSdWdsa2V2STFTSFBkYVlrRDJaUmE0bjZVLUxmZEh1UkFPbndtdWVDWmJBcEJaSmpTSlN4RkFkdF9EYkhFUXh3YWxqREkxRllfRXE0bFVuSkMwaExFNmk0UmNoa2R2NmQyb0p1N2pudENMMGMwWmVGT0J5SUxfeE5hT2hpUms1NHR4NzY1VWpNQVFYUWJkUnN3?oc=5", "source_name": "TradingView", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Therapeutics Details Post-IPO Pipeline Push, Sutacimig Phase III Plans", "summary": "", "url": "https://finance.yahoo.com/m/0fa3e16a-7755-3cdc-ba8c-e4ee52fc8acb/hemab-therapeutics-details.html", "source_name": "MarketBeat", "published_at": "2026-06-09T03:03:51+00:00", "published_display": "09 Jun 2026 03:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference", "summary": "", "url": "https://finance.yahoo.com/news/hemab-therapeutics-participate-2026-jefferies-120000861.html", "source_name": "GlobeNewswire", "published_at": "2026-05-27T12:00:00+00:00", "published_display": "27 May 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Goldman Sachs initiates Hemab Therapeutics stock with buy rating on rare disease drug potential", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6wFBVV95cUxQSjZjN3ZJejRWaDB6Ri1PaWdJNkdMMFVXYkl0OWFLbVZuQ0Z2RTI4TThiZEotYlVCWHlYcjBxWTE5bzRobXZxaUU0NEpSMkRGdTFIZEdjUjgyT2RIeW5nWjh0cnJSUVkwN1psZ3RZcjBOb0s2WjJuREFuV0RqOG5HTDJFYlpzNnFpRE41ZXZ5UDF4MXNqN2dyWlBFX21Kc3d5cWJ4cXRzRE9nX0JyNXY2dlE1UGcwTWNpN2Nkbi1Ua3NDWFlWcWFNR0JjLUprUkJ4M3hXUWtaZmItdFJfcnBXLWxTSWJ3YmgzNEJR?oc=5", "source_name": "Investing.com", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Therapeutics Reports First Quarter 2026 Financial Results", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/hemab-therapeutics-reports-first-quarter-110000642.html", "source_name": "GlobeNewswire", "published_at": "2026-05-21T11:00:00+00:00", "published_display": "21 May 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "PDS BIOTECHNOLOGY ($PDSB) Releases Q1 2026 Earnings | PDSB Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOcEdqLWM1SmVuNHpvZ2poNU5mOFppaWNtUi1IQVRHTmgxLUpyZHdUSDRnekdzMmVFQzFzUGo2RjlYenpCaTlfcUZhMm1yTzRwWUxnM01WY0libmxIVXNSM3RtMGxMY2RURTdMVW96bGU0SGZXRkE2SnVQdVNNUWw5RWtJQVJMX2pQQnRBRHBKMlRCUDct?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxOWWM3V1pmZzdlY1llRTljQmNLQ2UwdDdQaFVEcng2WVdrNE9qNzRrNVpBVlJNMGltQUhBUG1qellCVHNiM09fUkFHRW1kMEpvazJoLU11N3c4YnlWUXpmVl82aWNKeTA4U1RwSHNNSVd4d0lwWHRJclQ2TGNHWUpBQTgzbTBMVk05VGxYN0RwcmpTYklOQUFSWDhsSHZlQVpndmlPRGNvTmRmeHNILWg4ZE5jMjRoN01XNENiaVU2UDUyOWJfYUZCTm5URmtwTHJsTjJYNHo3RkxsQjBSMnBmdVZVWkFwN2PSAewBQVVfeXFMT3htM016bEt0TTdyOXE2amppMGpubTNfOFU4cGpxd2dFZkJDTjR3c0ZqOHpHYWZoamNLdmkxVmNYNklxTEM4NTU0bDZwUTZ1SW5Jc1c4NmRJN3lKQUVqUUNYYWptd2ZYNE9TeEhMRzFvbEt0bjk1TVhyVG44UnJnNDllTlFsalJVUTZwcEEzWXljbzdaQXdWWDlHQW56bGxqeG90UlFmaFFLekJlUlNIOVE4SGNHcE9pOW1KSllleVdwNERiaVl2NmxtNTNyaUtnSFY1VHUzcDJsWE9xb3R1ajZ2RGhkXzJzTldMOVA?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Hemab Therapeutics (COAG) Stock Trends and Sentiment 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTE9EdnBnTHdOcXJqMFZJWUo1NmtWZ3JneDdqbEQ2QlpIYlY3N05heUh0MXdONXpIdVpUTS1vaUZJOTl0aGJ5YkVNVUg2UFdMTWZTYzV6TmFfZzdkbGZDcE1HQmFoSTBIc1Q2UG1VcGtadVlMVDZONmc?oc=5", "source_name": "MarketBeat", "published_at": "2026-05-04T15:33:20+00:00", "published_display": "04 May 2026 15:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab's stock market debut brings in $346.7M after banks buy more shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOWTFQaV85MnROY2c4aW50REtUWjlhTHZlUDlBajVfaHNHdVFnQ1hYaWpwNG1FcjR6YXROMUlhZi1kckszZGJ0V2RaNWpGeTRBbjZQcVNicExZYTRkR3hRd1lBa0REZ1B1ZmF3M2hSRDUzemRfaXdOVFF0eV9yZ1E3eWlmckItdzA2NC1ONVNnTHJVZ0xTdWJLMkE3dTlaQzlkZ3VuWVZ5UDNZQV9xY0VneVRNaVFPSnFz?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Therapeutics IPO Debut Puts COAG And Pipeline Risks In Focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxOZkRLNHlvMXM2VGJwN0Z2N2FmTWdzaVlQUk9pc3Y5clFVNFhxQ1I3SlZIWXZma1FOV2tTNERpeDJ4eUptbEtlQ3NNaUtXN0taZjRUWnU0aDFJNzdDWWJSdDQ1STVHeDFFYXh5WjEtU0thYzRkSjFTWFFjeFNOQTdUR3FERUluWVFNNE5TX3V4N21sYTE1MGNQZmtNN09KTFU?oc=5", "source_name": "Market source", "published_at": "2026-05-03T07:00:00+00:00", "published_display": "03 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Therapeutics Holdings Company Profile & Introduction", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowJBVV95cUxPd0xDWFpKRlI1WUtGMmw2UER0Q09UWmYxSGFvYlhSa3V2MmtrMDAxRnIzUXlqMm93Y200b21EdUIwTFdUV0tFcWlYQ1l6WTRBb21PRTIzVm10NmhzZDVadG42dHFNTXRrZ2s4T2NjS1VzMmRKX1dvUzlMdGhtWl8tQ0tPSW1OalBhZnNYbk1UX21QN1ZBa0p5ZkVpeVk4VVRoN19VNGpLbjhVWWNFMWJwZHNBcFhjbzhJNUpLcDNHU2pPWk1vMGU4Zk1yd2VsQTVpUFZFSDR1TGg5dElCTzV2RnB2ZG1EVTlKR1JVNDQ4ZDE2dXZXSkRkOHo5TjU5ZHl4OU9YOUpTakdqdGFRY2VBRU1OdHl0aVFhRzFsaXlZZUpIR0k?oc=5", "source_name": "Moomoo", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "COAG|Hemab Therapeutics Holdings Ord Shs (Proposed)|Price:38.030|Chg%:+0.830", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE5JUGhSUDZYbGFHOUtJRi1qZ2FabFVabjJVblhRX3Z0YUYyTThYSVBWNm5DRjBzNU1PVEN4Rm56amZpZWdwYWlERElCekpydm9BOTdkSF90UFQteFZDYnZBTzlmbkVUUTVCVjg3NzV3?oc=5", "source_name": "TradingKey", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HEMAB THERAPEUTICS HOLDINGS (COAG) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9jUlJXcUoxaWcxVXQxQi0yeEEyZERTcGtJdW9Uajd5eC10a3k5cGhyLU9hZlk4THdISmlQNkVrS2lrN3M4Wk9wc0lfSDZuUjVIbzU4?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-30T23:25:08+00:00", "published_display": "30 Apr 2026 23:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "$301.5M biotech IPO puts Hemab on Nasdaq as COAG Friday", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQTTY2SENDaVlFVW1LYlJWX3JwMktHRWpyOHRyOVEzQUtUbmdGNnlKcXM4UHBjR2pKY2JISVAyRG5xQ0lrVURkX3FHOG5lY19XUFBGZFBOV0FVM1VNVFVTZzlkRmFkc0x6RzNlVzJMdy1td3JNbHZwQjJQbGxrUGo5Q0oxQko2Y1dLaDN0RHFDOFp5dkNlZ0dMVTNId3o1cF9lLXlKbkVzMXZ0WmhDNEcySTRoRFVjanZZ?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUjRRb0hlcHlOazlmelFaVVJSQWNnRmExZVBEQW1HMmVLTjNyU3d4WElsU05hdGlfYWFSY0twMTNWOVVCY0h4U2dYQ19BQl9pa3o0NWNBLW50WmFsSEVHdmJFV3JabnN5MFZpUWZabjZzY2tjMUtxbndONm9DS3NxTUp3Qjg2dWZnMDR2NXZ2eU80MWhSODVKdVgxZVJ6TWs3RFpCaDFqMXVtVkhmRVlOcWtqYUV1X1FPcGpfdERhRmwzdkZDaWxtSnJnd25Oam4yTnFHTFBkZi0tM1BZdkE?oc=5", "source_name": "StockStory", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Seaport, Hemab launch US IPOs as biotech listings gather momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPTnlOQkR4VkhDYnZXbHlLTjktQ3c3UGlKX0dMdzNFcEJQcDczREs5alNJRDFwNWhqajZaSjNCS3k2NTIzZVpqVG9zUy05QnNETklpYjNDclJQUG5vRmg0Y25IZ1B3Z3JndVdqUmpYN1c4eVljWkFxbHVqc0VQZHJ3Sy11TGZBUU1OWjNWVlk0WjQ2SnFLZ215TXNNRm15eHZWaU9wMU1tQWlJX2d1R2hLbkRpVHZjMjMtSW4wMVpCTFhNR1k?oc=5", "source_name": "Reuters", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOc2thQjFpazgwaFRfS3NjVXhlTkdFWHNFb240S0Z6akFtQXFIMmFmaXZnQ1A3OFVCQW9DT25OLVBQdGN5Yk52Mk9yUFlSX19ZS3FRTjZoR05zc2FVc25pVHQ0TDVHT2JmVnJabGNCREdLT2stV0IzLVdHWXpFZGU3V1NnVGhYbFRzNURVek41TVRmLWZQZTFYUkc4aXM0a1cwTkNFYTBfVnQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "COAG Stock Price and Chart \u2014 NASDAQ:COAG", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE11UFY0eFpaa2wwQ1pXY3B6a0l1Z0RDTjNNOVVEZURGc3JWTjRueF92aFJjTmZUV1diOFNiTVBISTlIWDdILUM2YUIxaEFxeTJvN1BTenB0Vl9GdUMt?oc=5", "source_name": "TradingView", "published_at": "2026-04-15T13:09:21+00:00", "published_display": "15 Apr 2026 13:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Long waiting lists and geopolitical headwinds could pose a challenge to Hemab\u2019s IPO plans", "summary": "", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTE1HYXBVcGVETTFQRW1XRGQxNm4tQ1ZmWENOZ0FlQ29QSU52Y0cxTHB1ZTJxQ0RBa1BMMUNGOFV3SHpKZ0pqVGRRZ2tGWmJLRUdCSnEwUVZsM1I2eTBSSXVXNklyU0NOLVpETEZDQndpRQ?oc=5", "source_name": "medwatch.com", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Therapeutics moving towards Nasdaq IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNVzJka1BqMzdHRFRKSE54MENQb3J1SXpic21jODZZNkh3ZWt2QUFRbG9GNHppUnprWDUycGVHOF9Sc1Y3ZFZnNUhQekVDbzNXZnhaLXBIUGpFWk9hRWdWQl84RjFUa29rUkVVNHkxc0lXV3JpTWxSUEhtcmJSSGFPcEFoSmJlamJ0?oc=5", "source_name": "AllSci", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNTTJZRVF4TFNBb3BhMW9VUnBnMVZhenZLNlZJY3Ryc3pGZ3dhZXBDY3pId0I5NFdmVTdiR2EyNXNBZFFuQ1M2M3pUTlRZdXJkbGxaT29mWm4wTG5fU2RtV1hIZWRwZUVNb3BEbTZKX3NPRV9mZVpiY3JBZDdMSDRveW1Jb0lIVmRKLVlidA?oc=5", "source_name": "Market source", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUEQ4TXY0R1lWMTJIcEJySm5iaEl1UkJ6TDMxcUtQYVl3UmxYdlJnaElpdlJDLU0xTTRvT0dsellqX21Tc3lxWW9IbWxHMnFBZGlxajdnUUU2OTNVY0l3NUh0OExMUENwWGxqY1d5dXV3YmRDZm9IRzc1c3FjbUh2cGxvdEJMZ25lYXdjSUliZ0txSjVFOHJhUXNTajBLeVV0M3B4dDk4V3dfQQ?oc=5", "source_name": "Kavout | AI", "published_at": "2026-02-28T09:53:07+00:00", "published_display": "28 Feb 2026 09:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNeEtXZ1k1WGctLWZuX0tYZE5SLWN4MU5KUktLV3NobzVheFpoMkZhdFJrWTdNelAwWGxYZUswazZtMWFUaXEzY3k0QnI0TW9IMGc2UTNzUlNmR1JxZG1JbEpQM0N3N1p4blRjaGdvMExoZzJOYWF3Tk5hajJCTlprZ3dESTVEd0Y4TXhvcElNR3Bqemd3RmNKcGxwa2dSU2phak9paE53c0t3dVFVeGZic2liZ1I0UU80TEM2WUNlOA?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSG1pQzVIRmhqTkhiWXozT29mTWM0UERfakxmOTZzdm5TZ24wZTVqLUpSWlFyWGVmYnlicGE3ZVYxOVotWU5naGM5aUZVakItUGJLTk1ZVE1mclRHd1N3N0FIWkV2TzFrT2lMNFRjcHhnVVBzTk5vNUFkLTgwNExtRWJYN1hVZzRkVjRlTktkNk1jcnpfQklCamN3NA?oc=5", "source_name": "Barron's", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UnitedHealth Stock Plummets 20% After Earnings. Why Soft Revenue Isn\u2019t the Only Problem.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxPMTdzUkZQWG9tTW9zT3FxSWtzdkdLLUNYVkRJMDh2X1VRSlVrdmVkS3FCSVFpX210VUxVSUF1Q2FYakw1ZUxyQlpoZHZpM1RYQzBOYlpEWENxeGM1bXBZNFYxQjZRcFBpcS0tVVhRdzFTejBrVzU3aU9QQXdnYkZBMWxB?oc=5", "source_name": "Barron's", "published_at": "2026-01-27T08:00:00+00:00", "published_display": "27 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Hemab Therapeutics (NASDAQ:COAG) Trading Down 3.8% - Should You Sell?", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxQRG5GcGVsakpUb3FoS3FPODlxMkdpQ0daYWZuNlMxSDlvVG1Rc3I5ODVONTdjVXd5NHEtX2VqcnVPTFpMT2pUX2VLbjNYYy15TWFuUGVBeHFwSElJTW04Uy1YaXlCNFpqN0dKOEx3OWJFRzAyQmQ5SFp1eEtCMTk3S25yUkV4YUFNbnhWeHQwRWNMMzNnbWhEaTZuVzJlTWlLOHROZlVGTnlSTWRscW1uWGw4dnVmUQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-15T16:26:57+00:00", "published_display": "15 Jul 2026 16:26", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Therapeutics: A Cash-Rich Coagulation Franchise With Multiple Clinical Catalysts", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxPdFliWmFUNnhhcWxQZFpIMlN1OWI0WlNsLUdWSWxxMVNtODVWSGMwQlpHX1QxSW51dDVSZzBybW4ydllrdGNGYks5S1ZINmJNdi1sTEdPY1lVQkRBd0ZSX05neFVGNF96cDBHeGpBenNSUGtTR29EV2xJSlZCR2VRekJjM243OU5GR2R6UVBwSEt4clIwVExyZmhkRUZGVGZFeWFCaW1xTlVrOUxoX0FKUjVwR0VGYU1rZnl0c2x3aXMxWGFJY1V1c3AtejZxYnF3?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-15T07:52:28+00:00", "published_display": "15 Jul 2026 07:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "symbol__ Stock Quote Price and Forecast", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE5KdjVOVWFBTG9HVTZVZXNKUGFEUmQ1WjdLbDRRaXlyTW5hcWpyVFdPMDhYMzg2OVJxSXhsem0zN1BhRG5xRFhtWEZIT2RualVX?oc=5", "source_name": "CNN", "published_at": "2026-07-15T01:05:31+00:00", "published_display": "15 Jul 2026 01:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Therapeutics reports positive Phase 2 sutacimig data", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNT3NjVXhld2ZVZDNEcXk0WEVFTGExRnVvV1RSRjNCRTFOS2h4YkJxMHdiYW81UTdmUXRtbkppYjJqUkVJTXprb0g3eTVvOW92aUZQZ3VnUXdrdDNIZk5kVzV2WjJaNlJpS20yVWpKcVNrc2ptaG9rZDhzbXNPQXIxRzBKVVhyVEhKMDRiXw?oc=5", "source_name": "grafa.com", "published_at": "2026-07-14T16:28:00+00:00", "published_display": "14 Jul 2026 16:28", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Therapeutics (COAG) FDA Approvals, PDUFA Dates & Drug Alerts 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiaEFVX3lxTE92dDhuUkJRWWJjX09DQVJhS2RjUXR6cERQOVh6SmV2UElVby04al9xXzNvR1NILTJnejRlQjNsTDF0MGw2NTQ2U2FRclNFYS1UY3FfbjFyZzRvb0RQYWZ1UTkxS2NtMndH?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-14T16:19:28+00:00", "published_display": "14 Jul 2026 16:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Advances Bleeding Disorder Pipeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQYUMtVGc3VGRpUTVzVjlzdXh2SFBmS3FwOExqalFLbGlFejJBM2ZEZ3NLNDMxM1phV2ZPSFhiVzM2M3BwSC1hWlVUSHkwTWJoWkFIZVRTRVlKQjQ0dkNPbWxCWTdldU5SdTU2dzlKbXVYaGR6c0p1TkNTUDh6TlZOYmt4NVhwUElfUzVsYTdoakNyby1ZeHFnMg?oc=5", "source_name": "Sahm", "published_at": "2026-07-14T13:24:44+00:00", "published_display": "14 Jul 2026 13:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Therapeutics Presents Clinical and Preclinical Data from Sutacimig in Glanzmann Thrombasthenia and Factor VII Deficiency at the ISTH 2026 Congress", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/hemab-therapeutics-presents-clinical-preclinical-114500576.html", "source_name": "GlobeNewswire", "published_at": "2026-07-14T11:45:00+00:00", "published_display": "14 Jul 2026 11:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab GT study finds 72% of patients 40+ still bleed weekly", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPTmE1NUNZWUl2ZGpSVVN6YzNWcWZDV2RXeU9UeWRYeE5vdk4wUHFpdmlITVFqNlZmYko0WXdjVTdpQVFPX3NNV1duUGxDc1RLNGZnRDZadDdjVzE1TXF3cGxLSXNkX0ZKSkVHcEN3SmNEbmNaVmNLam9BMV9vNEI0QkJpaG1QV2lLTEVkTkcyOTB6YjM2VjJidGtJbWg4YVhYUGt6X0J2Q3JOV3NvRXlQWWFRdGdyZTdP?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-14T11:45:00+00:00", "published_display": "14 Jul 2026 11:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jefferies Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Raises Target Price to $47", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOOHZoTlo2SkEwMTRPV0xZRVR0cktTSWh4QzIzalZqN1B4LWk2eFlfaFVNWG9IR2lkWWZUR0M2UHJNM05kc3RXcl9lZF9oM3BOdmF6TVROaEhKdXN3NkVrM2lNMG5iTG5SOTliRy1fa0RreHBhRmlJOGdXNkNoWTNaSmRxOVpDSm1vT0FlX3NXRnd3M1hfUEZha2N3al9zd1lvcmU0M3B2MDNNdmlXUG43ak5ic0JpeFpLLWc?oc=5", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-14T11:34:47+00:00", "published_display": "14 Jul 2026 11:34", "sentiment": "positive", "sentiment_pct": 82, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "H.C. Wainwright Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Raises Target Price to $52", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQM0h4YUE1YVE4RDVvcS1ld05yOUoxUzVkWXg2ZmRxd212eFFLTDRHTmx6cnhtWlcyM2NkQk9JTWZwRXhsM29qVEdUSUN6bkhGczE2dGVFcHhTb3lwOUtidU4xUlFhNllhdk53ak1LM05VQnlJQjFWUnRybG9UWDktYWJYMXZOWk1sRFIyUU1wMG5WT29pSGx0OXg4bXJyeTRNRUNfc21aOGNvUmd1OXNMaDJ5WUZJM00?oc=5", "source_name": "Moomoo", "published_at": "2026-07-14T03:53:03+00:00", "published_display": "14 Jul 2026 03:53", "sentiment": "positive", "sentiment_pct": 82, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Therapeutics' HMB-002 Well Suited for Type 1 Von Willebrand Disease, Wedbush Says", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/hemab-therapeutics-apos-hmb-002-144209017.html", "source_name": "MT Newswires", "published_at": "2026-07-13T14:42:09+00:00", "published_display": "13 Jul 2026 14:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Therapeutics (NASDAQ:COAG) Earns Outperform Rating from Wedbush", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOZVptNWRMYWdxV1RodmQ4UkV4aVU4LXNyTkhHZGJPUkRSRXN3QS1FU3EzSXB5aUw4SkFxLWxEN1p6cVlXS3lfUUJHaUc1b0FJMDJTNEpReW5pVzlCSHI3OFFmYlFGSlNlUWd5bnhNU1lMQ25CQl9tVDFIV0tCWHpBdXJSd2dTUXgtN2hTa0tRS09iWXpWRXZEcFZpd3ZqYjZZU1F6OG5TX0dCbGRWcW1CYUFiUVBMMXJaYkVDOQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-13T13:43:55+00:00", "published_display": "13 Jul 2026 13:43", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Therapeutics (NASDAQ:COAG) Price Target Raised to $52.00 at HC Wainwright", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxONTRpZ1JXMHNESHcwNG9FMENhYmJqNW1PVEhCcUlIN0k4ZkEzUnBtZC1OQkQwTnpLSUVvWWRBSGJRN00zSzJZYW9sMWMzUFUyNTJ2YUQzcDFtMC1kZWR0Q2ZHcG1xX1ZyU1E2ck5oVk83bnEzcE9qTEd2YnBKdTBpbVd4R1luNVUwN2VJRHJXZTVpYWMxQnZPZHR0Y2Y5TDBZMFVvQ3JnUFRubmd3enJPSTZrRXNIUVc3eDJvcWQxRHVhY1hCNk44?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-13T12:39:22+00:00", "published_display": "13 Jul 2026 12:39", "sentiment": "positive", "sentiment_pct": 64, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wedbush Raises Price Target on Hemab Therapeutics to $55 From $42, Keeps Outperform Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/wedbush-raises-price-target-hemab-105444800.html", "source_name": "MT Newswires", "published_at": "2026-07-13T10:54:44+00:00", "published_display": "13 Jul 2026 10:54", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPQ3B5MlVsTlBhcXdmUVllazV2SWFHTmRudHVNdFY3RUYtR1FTXzNIV1VYODF0bTMyVThkOE1LZC11TGN2dUxBZzRPTDQxUDVDdF9PWW5VUk1rZVJkdXRjbTQ2MU1wa3BtejZ5NUhWY1dQLUZLS3duak1fMzIxcnNwUmc4X3N5Q1JXMFNQY1J0ZVd5aHF4NHVUQkpnNlNUU1VWcVljNjhGbkFicUNyOXktR0lZWkVxT09oU0VQZnZObG5RMkJDWHh4czRrUktNZFNrZVhKWnF1YTZ2ZmVzTG14WG1n?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:24:17+00:00", "published_display": "13 Jul 2026 09:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/hemab-therapeutics-presents-clinical-data-102800569.html", "source_name": "GlobeNewswire", "published_at": "2026-07-12T10:28:00+00:00", "published_display": "12 Jul 2026 10:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the ISTH 2026 Congress", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/hemab-therapeutics-present-clinical-preclinical-130000267.html", "source_name": "GlobeNewswire", "published_at": "2026-06-26T13:00:00+00:00", "published_display": "26 Jun 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Therapeutics stock jumps on pipeline data presentation", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNZm50VGp3NGlXQzVQTUVqMXV4N19hTWJ3ZVlZdldUN0h3T29USk9CVUlEVzNJd1IzUDZtcG14TC1RYTJieVNIbmthaktsQlB3QnpHWXdUcnBQbHpsazBuZ3JqLWpubG80UWZEMlQ3Q1Z3VzhRWmI1OU9qYWc4QndnRS00WW9hRlQ0SldTNzQzZnVscE5IN1dFa1hoMklJV2xQTWNzcC1SN2RRMUJHa0ZIbU85VTJrUXExZGtyb04xVQ?oc=5", "source_name": "Investing.com", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab brings nine bleeding-disorder studies to ISTH 2026 in Paris", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNTms5MGJFanUxSXMxRWFCZ2lpNklnY3JJVmNUMm1lSXFnTGhxQWtqWU9xRkRudWtHUEdtZkppZDhMQ2kyaHNuZi1GMEFndFNKMnhfSmJpTTBwRWgxWjFDSlIydm92UXNIRThBTGxOblVJNll6dEFDRWYxWllYa05xd2x3THpnMVRqVndkdllXWUg5Mk1BbTFrbkhmMDVrWHE2NDhXRE5wY3l1SHFJQmVmbV9GWjNhTG9FRGw4?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQM0ExNm9zZVBVMzB2cTFsYkhQeDJyeUV5Y1lSdWdsa2V2STFTSFBkYVlrRDJaUmE0bjZVLUxmZEh1UkFPbndtdWVDWmJBcEJaSmpTSlN4RkFkdF9EYkhFUXh3YWxqREkxRllfRXE0bFVuSkMwaExFNmk0UmNoa2R2NmQyb0p1N2pudENMMGMwWmVGT0J5SUxfeE5hT2hpUms1NHR4NzY1VWpNQVFYUWJkUnN3?oc=5", "source_name": "TradingView", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Therapeutics Details Post-IPO Pipeline Push, Sutacimig Phase III Plans", "summary": "", "url": "https://finance.yahoo.com/m/0fa3e16a-7755-3cdc-ba8c-e4ee52fc8acb/hemab-therapeutics-details.html", "source_name": "MarketBeat", "published_at": "2026-06-09T03:03:51+00:00", "published_display": "09 Jun 2026 03:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference", "summary": "", "url": "https://finance.yahoo.com/news/hemab-therapeutics-participate-2026-jefferies-120000861.html", "source_name": "GlobeNewswire", "published_at": "2026-05-27T12:00:00+00:00", "published_display": "27 May 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Goldman Sachs initiates Hemab Therapeutics stock with buy rating on rare disease drug potential", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6wFBVV95cUxQSjZjN3ZJejRWaDB6Ri1PaWdJNkdMMFVXYkl0OWFLbVZuQ0Z2RTI4TThiZEotYlVCWHlYcjBxWTE5bzRobXZxaUU0NEpSMkRGdTFIZEdjUjgyT2RIeW5nWjh0cnJSUVkwN1psZ3RZcjBOb0s2WjJuREFuV0RqOG5HTDJFYlpzNnFpRE41ZXZ5UDF4MXNqN2dyWlBFX21Kc3d5cWJ4cXRzRE9nX0JyNXY2dlE1UGcwTWNpN2Nkbi1Ua3NDWFlWcWFNR0JjLUprUkJ4M3hXUWtaZmItdFJfcnBXLWxTSWJ3YmgzNEJR?oc=5", "source_name": "Investing.com", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Therapeutics Reports First Quarter 2026 Financial Results", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/hemab-therapeutics-reports-first-quarter-110000642.html", "source_name": "GlobeNewswire", "published_at": "2026-05-21T11:00:00+00:00", "published_display": "21 May 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PDS BIOTECHNOLOGY ($PDSB) Releases Q1 2026 Earnings | PDSB Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOcEdqLWM1SmVuNHpvZ2poNU5mOFppaWNtUi1IQVRHTmgxLUpyZHdUSDRnekdzMmVFQzFzUGo2RjlYenpCaTlfcUZhMm1yTzRwWUxnM01WY0libmxIVXNSM3RtMGxMY2RURTdMVW96bGU0SGZXRkE2SnVQdVNNUWw5RWtJQVJMX2pQQnRBRHBKMlRCUDct?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Therapeutics (COAG) Stock Trends and Sentiment 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTE9EdnBnTHdOcXJqMFZJWUo1NmtWZ3JneDdqbEQ2QlpIYlY3N05heUh0MXdONXpIdVpUTS1vaUZJOTl0aGJ5YkVNVUg2UFdMTWZTYzV6TmFfZzdkbGZDcE1HQmFoSTBIc1Q2UG1VcGtadVlMVDZONmc?oc=5", "source_name": "MarketBeat", "published_at": "2026-05-04T15:33:20+00:00", "published_display": "04 May 2026 15:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab's stock market debut brings in $346.7M after banks buy more shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOWTFQaV85MnROY2c4aW50REtUWjlhTHZlUDlBajVfaHNHdVFnQ1hYaWpwNG1FcjR6YXROMUlhZi1kckszZGJ0V2RaNWpGeTRBbjZQcVNicExZYTRkR3hRd1lBa0REZ1B1ZmF3M2hSRDUzemRfaXdOVFF0eV9yZ1E3eWlmckItdzA2NC1ONVNnTHJVZ0xTdWJLMkE3dTlaQzlkZ3VuWVZ5UDNZQV9xY0VneVRNaVFPSnFz?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Therapeutics IPO Debut Puts COAG And Pipeline Risks In Focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxOZkRLNHlvMXM2VGJwN0Z2N2FmTWdzaVlQUk9pc3Y5clFVNFhxQ1I3SlZIWXZma1FOV2tTNERpeDJ4eUptbEtlQ3NNaUtXN0taZjRUWnU0aDFJNzdDWWJSdDQ1STVHeDFFYXh5WjEtU0thYzRkSjFTWFFjeFNOQTdUR3FERUluWVFNNE5TX3V4N21sYTE1MGNQZmtNN09KTFU?oc=5", "source_name": "Market source", "published_at": "2026-05-03T07:00:00+00:00", "published_display": "03 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Therapeutics Holdings Company Profile & Introduction", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowJBVV95cUxPd0xDWFpKRlI1WUtGMmw2UER0Q09UWmYxSGFvYlhSa3V2MmtrMDAxRnIzUXlqMm93Y200b21EdUIwTFdUV0tFcWlYQ1l6WTRBb21PRTIzVm10NmhzZDVadG42dHFNTXRrZ2s4T2NjS1VzMmRKX1dvUzlMdGhtWl8tQ0tPSW1OalBhZnNYbk1UX21QN1ZBa0p5ZkVpeVk4VVRoN19VNGpLbjhVWWNFMWJwZHNBcFhjbzhJNUpLcDNHU2pPWk1vMGU4Zk1yd2VsQTVpUFZFSDR1TGg5dElCTzV2RnB2ZG1EVTlKR1JVNDQ4ZDE2dXZXSkRkOHo5TjU5ZHl4OU9YOUpTakdqdGFRY2VBRU1OdHl0aVFhRzFsaXlZZUpIR0k?oc=5", "source_name": "Moomoo", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "COAG|Hemab Therapeutics Holdings Ord Shs (Proposed)|Price:38.030|Chg%:+0.830", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE5JUGhSUDZYbGFHOUtJRi1qZ2FabFVabjJVblhRX3Z0YUYyTThYSVBWNm5DRjBzNU1PVEN4Rm56amZpZWdwYWlERElCekpydm9BOTdkSF90UFQteFZDYnZBTzlmbkVUUTVCVjg3NzV3?oc=5", "source_name": "TradingKey", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HEMAB THERAPEUTICS HOLDINGS (COAG) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9jUlJXcUoxaWcxVXQxQi0yeEEyZERTcGtJdW9Uajd5eC10a3k5cGhyLU9hZlk4THdISmlQNkVrS2lrN3M4Wk9wc0lfSDZuUjVIbzU4?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-30T23:25:08+00:00", "published_display": "30 Apr 2026 23:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "$301.5M biotech IPO puts Hemab on Nasdaq as COAG Friday", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQTTY2SENDaVlFVW1LYlJWX3JwMktHRWpyOHRyOVEzQUtUbmdGNnlKcXM4UHBjR2pKY2JISVAyRG5xQ0lrVURkX3FHOG5lY19XUFBGZFBOV0FVM1VNVFVTZzlkRmFkc0x6RzNlVzJMdy1td3JNbHZwQjJQbGxrUGo5Q0oxQko2Y1dLaDN0RHFDOFp5dkNlZ0dMVTNId3o1cF9lLXlKbkVzMXZ0WmhDNEcySTRoRFVjanZZ?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUjRRb0hlcHlOazlmelFaVVJSQWNnRmExZVBEQW1HMmVLTjNyU3d4WElsU05hdGlfYWFSY0twMTNWOVVCY0h4U2dYQ19BQl9pa3o0NWNBLW50WmFsSEVHdmJFV3JabnN5MFZpUWZabjZzY2tjMUtxbndONm9DS3NxTUp3Qjg2dWZnMDR2NXZ2eU80MWhSODVKdVgxZVJ6TWs3RFpCaDFqMXVtVkhmRVlOcWtqYUV1X1FPcGpfdERhRmwzdkZDaWxtSnJnd25Oam4yTnFHTFBkZi0tM1BZdkE?oc=5", "source_name": "StockStory", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Seaport, Hemab launch US IPOs as biotech listings gather momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPTnlOQkR4VkhDYnZXbHlLTjktQ3c3UGlKX0dMdzNFcEJQcDczREs5alNJRDFwNWhqajZaSjNCS3k2NTIzZVpqVG9zUy05QnNETklpYjNDclJQUG5vRmg0Y25IZ1B3Z3JndVdqUmpYN1c4eVljWkFxbHVqc0VQZHJ3Sy11TGZBUU1OWjNWVlk0WjQ2SnFLZ215TXNNRm15eHZWaU9wMU1tQWlJX2d1R2hLbkRpVHZjMjMtSW4wMVpCTFhNR1k?oc=5", "source_name": "Reuters", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOc2thQjFpazgwaFRfS3NjVXhlTkdFWHNFb240S0Z6akFtQXFIMmFmaXZnQ1A3OFVCQW9DT25OLVBQdGN5Yk52Mk9yUFlSX19ZS3FRTjZoR05zc2FVc25pVHQ0TDVHT2JmVnJabGNCREdLT2stV0IzLVdHWXpFZGU3V1NnVGhYbFRzNURVek41TVRmLWZQZTFYUkc4aXM0a1cwTkNFYTBfVnQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "COAG Stock Price and Chart \u2014 NASDAQ:COAG", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE11UFY0eFpaa2wwQ1pXY3B6a0l1Z0RDTjNNOVVEZURGc3JWTjRueF92aFJjTmZUV1diOFNiTVBISTlIWDdILUM2YUIxaEFxeTJvN1BTenB0Vl9GdUMt?oc=5", "source_name": "TradingView", "published_at": "2026-04-15T13:09:21+00:00", "published_display": "15 Apr 2026 13:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Long waiting lists and geopolitical headwinds could pose a challenge to Hemab\u2019s IPO plans", "summary": "", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTE1HYXBVcGVETTFQRW1XRGQxNm4tQ1ZmWENOZ0FlQ29QSU52Y0cxTHB1ZTJxQ0RBa1BMMUNGOFV3SHpKZ0pqVGRRZ2tGWmJLRUdCSnEwUVZsM1I2eTBSSXVXNklyU0NOLVpETEZDQndpRQ?oc=5", "source_name": "medwatch.com", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemab Therapeutics moving towards Nasdaq IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNVzJka1BqMzdHRFRKSE54MENQb3J1SXpic21jODZZNkh3ZWt2QUFRbG9GNHppUnprWDUycGVHOF9Sc1Y3ZFZnNUhQekVDbzNXZnhaLXBIUGpFWk9hRWdWQl84RjFUa29rUkVVNHkxc0lXV3JpTWxSUEhtcmJSSGFPcEFoSmJlamJ0?oc=5", "source_name": "AllSci", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNTTJZRVF4TFNBb3BhMW9VUnBnMVZhenZLNlZJY3Ryc3pGZ3dhZXBDY3pId0I5NFdmVTdiR2EyNXNBZFFuQ1M2M3pUTlRZdXJkbGxaT29mWm4wTG5fU2RtV1hIZWRwZUVNb3BEbTZKX3NPRV9mZVpiY3JBZDdMSDRveW1Jb0lIVmRKLVlidA?oc=5", "source_name": "Market source", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUEQ4TXY0R1lWMTJIcEJySm5iaEl1UkJ6TDMxcUtQYVl3UmxYdlJnaElpdlJDLU0xTTRvT0dsellqX21Tc3lxWW9IbWxHMnFBZGlxajdnUUU2OTNVY0l3NUh0OExMUENwWGxqY1d5dXV3YmRDZm9IRzc1c3FjbUh2cGxvdEJMZ25lYXdjSUliZ0txSjVFOHJhUXNTajBLeVV0M3B4dDk4V3dfQQ?oc=5", "source_name": "Kavout | AI", "published_at": "2026-02-28T09:53:07+00:00", "published_display": "28 Feb 2026 09:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNeEtXZ1k1WGctLWZuX0tYZE5SLWN4MU5KUktLV3NobzVheFpoMkZhdFJrWTdNelAwWGxYZUswazZtMWFUaXEzY3k0QnI0TW9IMGc2UTNzUlNmR1JxZG1JbEpQM0N3N1p4blRjaGdvMExoZzJOYWF3Tk5hajJCTlprZ3dESTVEd0Y4TXhvcElNR3Bqemd3RmNKcGxwa2dSU2phak9paE53c0t3dVFVeGZic2liZ1I0UU80TEM2WUNlOA?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSG1pQzVIRmhqTkhiWXozT29mTWM0UERfakxmOTZzdm5TZ24wZTVqLUpSWlFyWGVmYnlicGE3ZVYxOVotWU5naGM5aUZVakItUGJLTk1ZVE1mclRHd1N3N0FIWkV2TzFrT2lMNFRjcHhnVVBzTk5vNUFkLTgwNExtRWJYN1hVZzRkVjRlTktkNk1jcnpfQklCamN3NA?oc=5", "source_name": "Barron's", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UnitedHealth Stock Plummets 20% After Earnings. Why Soft Revenue Isn\u2019t the Only Problem.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxPMTdzUkZQWG9tTW9zT3FxSWtzdkdLLUNYVkRJMDh2X1VRSlVrdmVkS3FCSVFpX210VUxVSUF1Q2FYakw1ZUxyQlpoZHZpM1RYQzBOYlpEWENxeGM1bXBZNFYxQjZRcFBpcS0tVVhRdzFTejBrVzU3aU9QQXdnYkZBMWxB?oc=5", "source_name": "Barron's", "published_at": "2026-01-27T08:00:00+00:00", "published_display": "27 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxQSW9mM3I5d1lnaHgzVDlPNFgzSVg3MFNNVmk0N0hLcGh3dko0MF9kWUVzS1phTmdDU1NjUGFZamZZWTBmdnFfanllME9NWmhxd0JiMjJzM3JCQU9SVnY0cEx3T3JnT1pDUlh3Vy0xR1lDem9hZ2ZqdUFXd2UzU1JRbkczUEdHZ1hSRGdTN1JfSHgtLUxQVTBJRjNGbS15Z05pZVd0a25wZl9OX0VjNnp4WHVVOUxxeUVwbTJ1TmdMTzZvcEZVbTkzSDdEUFhvZTdtZC1fb3R2SFZ4ZzQ?oc=5", "source_name": "StockStory", "published_at": "2026-07-15T07:00:00+00:00", "published_display": "15 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 79, "total_relevant": 53, "sentiment_summary": {"positive": 12, "negative": 4, "neutral": 37, "score": 54, "total": 53, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 81, "events": [{"event": "general", "label": "Market update", "weight": 17.55, "count": 30}, {"event": "earnings", "label": "Earnings", "weight": 8.4, "count": 16}, {"event": "analyst", "label": "Analyst action", "weight": 3.3, "count": 6}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 12, "negative_events": 4}, "market_context": {"has_market_context": true, "latest_close": 38.03, "latest_week": "2026-07-10", "one_week_move": 22.7, "four_week_move": 52.2, "twelve_week_move": null, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.0, "market_dynamics_buy_signal": false, "relative_strength": null, "fair_value_gap": 29.7, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "negative", "expectation_probability": 42.1739, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+22.7% over one week, +52.2% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 63, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 7}, {"label": "MarketBeat", "count": 6}, {"label": "GlobeNewswire", "count": 5}, {"label": "Stock Titan", "count": 5}, {"label": "TradingView", "count": 3}, {"label": "Seeking Alpha", "count": 2}, {"label": "StockStory", "count": 2}, {"label": "Moomoo", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 45}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 30}, {"label": "Earnings", "count": 16}, {"label": "Analyst action", "count": 6}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "81/100 classification confidence."}, {"label": "Company focus", "value": "45", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "5", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+22.7% over one week, +52.2% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "Hemab Therapeutics (NASDAQ:COAG) Trading Down 3.8% - Should You Sell?"}], "updated_at": "2026-07-16T21:37:47.148745+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}